Acortamiento retinadola forma más grave de la vitreorretinopatía proliferante (VRP)
- JC Pastor
- E Rodríguez de la Rúa
- F Martín
- A Mayo-Iscar
- MA de la Fuente
- R Coco
- C Bailez
- S Mahave
ISSN: 0365-6691
Any de publicació: 2003
Volum: 78
Número: 12
Pàgines: 653-657
Tipus: Article
Altres publicacions en: Archivos de la Sociedad Española de Oftalmologia
Resum
Purpose: To identify the clinical characteristics of patients developing retinal shortening due to intraretinal PVR. Methods: Observational and retrospective cohort study on 110 PVR patients operated on between 2000 and 2001. During surgery, after removing epiretinal membranes and ruling out the presence of subretinal membranes, a perfluorocarbon liquid was injected. Those cases in which retinal flattening was not accomplished, were considered intraretinal PVR (group 1). Those in which retinal flattening allowed endolaser application, were taken as the control group (group 2). Clinical features of both groups were compared by chi-square test. Results: 60 cases (54.5%, CI 95%: 40.5-68.5) showed retinal shortening (group 1). In 24 cases (21.8%, CI 95%: 12.9-30.7) complete retinal flattening was accomplished (group 2). In 26 cases (23.6%), evaluation was inconclusive. In 9 out of the 60 cases of group 1 (15%) a retinectomy was necessary to reattach the retina. Differences between both groups were not statistically significant for any of the clinical variables. However, the number of retinal detachments of more than 60 days of evolution was significantly higher in retinectomized eyes (20.7%) than in group 1 (3.7%) (p=0.04). Conclusions: Retinal shortening is a relatively frequent phenomenon in PVR. Further studies are necessary to characterize this clinical presentation of PVR and its pathogenesis.
Referències bibliogràfiques
- (1983). The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 90. 121-125
- Lean, JS, Stern, WH, Irvine, AR, Azen, SP. (1989). Classification of proliferative vitreoretinopathy used in the silicone study. Ophthalmology. 96. 765-771
- Machemer, R, Aaberg, TM, Freeman, HM, Irvine, AR, Lean, JS, Michels, RM. (1991). An update classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 112. 159-165
- Pastor, JC. (1998). Proliferative vitreoretinopathy: an overview. Surv Ophthalmol. 43. 3-18
- Pastor, JC, de la Rua, ER, Martin, F. (2002). Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res. 21. 127-144
- Pastor, JC, de la Rua, ER, Martin, F, Mayo, A, de la Fuente, MA, Coco, RM. (2003). Clinical and surgical features of retinal shortening: the most severe and less recognized form of proliferative viteroretinopathy (PVR). Invest Ophthalmol Vis Sci. 44. 122
- Rodriguez de la Rua Franch, E, Aragon Roca, JA, Pastor Jimeno, JC, Carrasco Herrero, B, Gonzalez Rodriguez, JC, Alvarez Requejo, A. (2000). Posibilidad de predecir el riesgo de una vitreorretinopatía proliferante mediante el análisis de factores clínicos de los desprendimientos de retina regmatógenos. Arch Soc Esp Oftalmol. 75. 807-812
- Rodriguez De la Rua, E, Martinez, V, Aragon, J, Sanabria, RM, Giraldo, A, Mayo, A. (2003). Factores clínicos de riesgo para el desarrollo de la vitreorretinopatía proliferante (VRP) postquirúrgica: Estudio prospectivo. Arch Soc Esp Oftalmol. 78. 91-98
- Fisher, SK, Erickson, PA, Lewis, GP, Anderson, DH. (1991). Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci. 32. 1739-1748
- Lewis, GP, Fisher, SK. (2000). Muller cell outgrowth after retinal detachment: association with cone photoreceptors. Invest Ophthalmol Vis Sci. 41. 1542-1545
- Miura, M, Ideta, H. (2000). Factors related to subretinal proliferation in patients with primary rhegmatogenous retinal detachment. Retina. 20. 465-468
- Lewis, GP, Charteris, DG, Sethi, CS, Fisher, SK. (2002). Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye. 16. 375-387
- Coblentz, FE, Lewis, GP, Radeke, MJ, Fisher, SK. (2001). Identification of changes in ganglion cells and horizontal cells following retinal detachment. Invest Ophthalmol Vis Sci. 42. 445